NK cells lose cytotoxicity in the tumor microenvironment due to TGF-β and lactate, which downregulate activating receptors (e.g., NKG2D) and upregulate inhibitory receptors (e.g., KIR). The gene discussed is KLRK1; the disease is neoplasm.